ARCHIVES

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

In Brief: ACOS Analysis Finds Conclusive Shift To Modified Radical, Earlier Detection, Treatment For Blacks

September 4, 1981

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

NCI-Approved CTEP Trials For the Month of September

September 28, 2012

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989